MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹5.38 Cr | ₹7.25 Cr | ₹0.70 Cr | ₹5.60 Cr | - |
What is the latest Capital Work in Progress ratio of MARKSANS PHARMA ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹5.38 Cr |
Mar2023 | ₹7.25 Cr |
Mar2022 | ₹0.70 Cr |
Mar2021 | ₹5.60 Cr |
Mar2020 | - |
How is Capital Work in Progress of MARKSANS PHARMA Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹5.38 Cr | -25.74 | |
Mar2023 | ₹7.25 Cr | 942.59 | |
Mar2022 | ₹0.70 Cr | -87.59 | |
Mar2021 | ₹5.60 Cr | 0 | |
Mar2020 | - | - |
Compare Capital Work in Progress of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,459.2 Cr | -4.5% | -12.9% | 62.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,135.0 Cr | 2.6% | -1.1% | 38.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,074.0 Cr | -3.8% | -1.9% | 60.1% | Stock Analytics | |
CIPLA | ₹114,019.0 Cr | -2.4% | -5.2% | 10.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,192.0 Cr | -5.9% | -9.6% | 14.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,256.3 Cr | -3.9% | -0.3% | 40.6% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -4.5% |
-12.9% |
62.5% |
SENSEX | -0.6% |
-2.9% |
6.3% |
You may also like the below Video Courses